Towards this direction, we have focused herein on the pivotal clock component CRY2, which is critically implicated in DNA repair, cell cycle regulation, and chemoresistance modulation, thereby rendering CRY2 a novel and important (druggable) target for pancreatic cancer therapy [23,24]. This evidence concerns the gene CLOCK and pancreatic neoplasm.